Excited to see how it helps in the coming weeks
As with all medications, Semaglutide GLP-1 injections come with side effects and should only be used at the recommendation of a medical professional and exactly as prescribed
Exenatide extended-release (Bydureon, Bydureon BCise) received FDA approval in 2012, offering once-weekly subcutaneous administration
Generally, current treatments of IC are solely concerned with symptomatic relief of the condition, with the most effective course of treatment for the disease yet to be confirmed through continuing clinical trials designed to amplify the knowledge of the causative factors of IC, as well as to enhance the treatment regime (Lukban, 2003
Strober B, Bachelez H, Crowley J, et al
The GLP-1R monoagonists displayed a significant positive correlation between C ss and nausea, which is not observed for the GIPR/GLP-1R dual-agonist ( Figure 1F )